OTC Healthcare in New Zealand
Euromonitor International's OTC Healthcare in New Zealand market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 118 | Publication date: Jun 2008
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Limited growth continues
The OTC healthcare industry in 2007 as a whole, held its growth at a similar rate to 2006. This continued slower growth rate was due to a number of sectors experiencing low and even negative growth. Analgesics recorded slower growth in 2007, as did digestive remedies, but the largest decline in growth was in OTC obesity mainly due to lack of marketing in 2007.
Vitamins and dietary supplements recover
After a downward growth trend from 2005 to 2006, vitamins and dietary supplements advanced again in 2007. The trend for particular vitamins such as glucosamine, fish oils and multivitamins coupled with the resurgence in combination dietary supplements, helped vitamins and dietary supplements to recover.
Multinationals dominate
Multinationals characterise the OTC healthcare industry in New Zealand. In 2007 the industry was led by Reckitt Benckiser, closely followed by Johnson & Johnson after the acquisition of many well-known Pfizer OTC brands. GlaxoSmithKline followed in third place. Healtheries of New Zealand managed fourth place due to its dominance in vitamins and dietary supplements.
Continued expansion of the grocery channel
The continued expansion of OTC healthcare products into general sales status benefited the healthcare companies that have managed to achieve a product presence in supermarkets. Consumers, being well educated and informed through marketing strategies, are confident in self medicating in a number of sectors, namely, analgesics, cough and cold products and vitamins and dietary supplements, as well as skin care and eye, ear and mouth care products.
Forecast for gradual growth
Over the forecast period, OTC healthcare products are expected to record slower constant value growth. This is mainly due to the maturation of many products as well as the increased rescheduling of general sales for OTC products, which has led to the expansion of grocery sales. This means more competitive pricing, leading to volume driven sales. However, over the forecast period many players will revitalise these slower segments, through product innovation, value-adding to their products and finding niche alternatives to create a resurgence.
Table of contents
OTC HEALTHCARE IN NEW ZEALAND : MARKET INSIGHT
EXECUTIVE SUMMARY
Limited growth continues
Vitamins and dietary supplements recover
Multinationals dominate
Continued expansion of the grocery channel
Forecast for gradual growth
KEY TRENDS AND DEVELOPMENTS
Pharmacies struggle to maintain share
Expansion of grocery channel
Ageing population continues to help sales
Natural alternatives gaining ground
Changing face of OTC players
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2002-2007
Table 2 Life Expectancy at Birth 2002-2007
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2002-2007
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2002-2007
Table 5 OTC Healthcare Company Shares by Value 2003-2007
Table 6 OTC Healthcare Brand Shares by Value 2004-2007
Table 7 Penetration of Private Label by Sector 2003-2007
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2002-2007
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2007
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2007-2012
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2007-2012
APPENDIX
OTC Registration and Classification
Distribution
Vitamins & Dietary Supplements Registration and Classification
Generics
Switches
Summary 1 OTC Healthcare Switches 2005-2007
DEFINITIONS
Summary 2 Research Sources
LOCAL COMPANY PROFILES - NEW ZEALAND
AURORA PHARMACEUTICALS LTD - OTC HEALTHCARE - NEW ZEALAND
STRATEGIC DIRECTION
KEY FACTS
Summary 3 Aurora Pharmaceuticals Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
COMVITA NEW ZEALAND LTD - OTC HEALTHCARE - NEW ZEALAND
STRATEGIC DIRECTION
KEY FACTS
Summary 4 Comvita Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 5 Comvita Limited: Competitive Position 2007
DOUGLAS PHARMACEUTICALS LTD - OTC HEALTHCARE - NEW ZEALAND
STRATEGIC DIRECTION
KEY FACTS
Summary 6 Douglas Pharmaceuticals Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 7 Douglas Pharmaceuticals Ltd: Competitive Position 2007
EBOS GROUP LTD - OTC HEALTHCARE - NEW ZEALAND
STRATEGIC DIRECTION
KEY FACTS
Summary 8 EBOS GROUP PTY LTD: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 9 Ebos Group Ltd: Competitive Position 2007
PSM HEALTHCARE LTD - OTC HEALTHCARE - NEW ZEALAND
STRATEGIC DIRECTION
KEY FACTS
Summary 10 PSM Healthcare Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 11 PSM Healthcare Ltd: Competitive Position 2007
ANALGESICS IN NEW ZEALAND
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 12 Sales of Analgesics by Subsector: Value 2002-2007
Table 13 Sales of Analgesics by Subsector: % Value Growth 2002-2007
Table 14 Herbal vs Standard Topical Analgesics 2002-2007
Table 15 Topical Analgesics by Format: Retailvaluersp 2004-2007
Table 16 Analgesics Company Shares by Value 2003-2007
Table 17 Analgesics Brand Shares by Value 2004-2007
Table 18 Forecast Sales of Analgesics by Subsector: Value 2007-2012
Table 19 Forecast Sales of Analgesics by Subsector: % Value Growth 2007-2012
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN NEW ZEALAND
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2002-2007
Table 21 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2002-2007
Table 22 Sales of Decongestants by Type: Value 2002-2007
Table 23 Sales of Decongestants by Type: % Value Growth 2002-2007
Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2002-2007
Table 25 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2002-2007
Table 26 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2002-2007
Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2003-2007
Table 28 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2004-2007
Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2007-2012
Table 30 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2007-2012
DIGESTIVE REMEDIES IN NEW ZEALAND
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 31 Sales of Digestive Remedies by Subsector: Value 2002-2007
Table 32 Sales of Digestive Remedies by Subsector: % Value Growth 2002-2007
Table 33 Herbal vs Standard Digestive Remedies 2002-2007
Table 34 Digestive Remedies Company Shares by Value 2003-2007
Table 35 Digestive Remedies Brand Shares by Value 2004-2007
Table 36 Forecast Sales of Digestive Remedies by Subsector: Value 2007-2012
Table 37 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2007-2012
MEDICATED SKIN CARE IN NEW ZEALAND
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 38 Sales of Medicated Skin Care by Subsector: Value 2002-2007
Table 39 Sales of Medicated Skin Care by Subsector: % Value Growth 2002-2007
Table 40 Herbal vs Standard Medicated Skin Care 2002-2007
Table 41 Medicated Skin Care Company Shares by Value 2003-2007
Table 42 Medicated Skin Care Brand Shares by Value 2004-2007
Table 43 Acne Treatments Brand Shares by Value 2004-2007
Table 44 Hair Loss Treatments Brand Shares by Value 2004-2007
Table 45 Forecast Sales of Medicated Skin Care by Subsector: Value 2007-2012
Table 46 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2007-2012
VITAMINS AND DIETARY SUPPLEMENTS IN NEW ZEALAND
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 47 Sales of Vitamins and Dietary Supplements by Subsector: Value 2002-2007
Table 48 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2002-2007
Table 49 Sales of Vitamins by Type: Value 2002-2007
Table 50 Sales of Vitamins by Type: % Value Growth 2002-2007
Table 51 Sales of Dietary Supplements by Type: Value 2002-2007
Table 52 Sales of Dietary Supplements by Type: % Value Growth 2002-2007
Table 53 Folic Acid v Other B Vitamins 2004-2007
Table 54 Dietary Supplements by Positioning 2006-2007
Table 55 Vitamins and Dietary Supplements Company Shares by Value 2003-2007
Table 56 Vitamins and Dietary Supplements Brand Shares by Value 2004-2007
Table 57 Vitamins Brand Shares by Value 2004-2007
Table 58 Dietary Supplements Brand Shares by Value 2004-2007
Table 59 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2007-2012
Table 60 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2007-2012
NRT SMOKING CESSATION AIDS IN NEW ZEALAND
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 61 Number of Smokers by Gender 2002-2007
SECTOR DATA
Table 62 Sales of Smoking Cessation Aids by Subsector: Value 2002-2007
Table 63 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2002-2007
Table 64 NRT Gum Flavours 2006-2007
Table 65 Smoking Cessation Aids Company Shares by Value 2003-2007
Table 66 Smoking Cessation Aids Brand Shares by Value 2004-2007
Table 67 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2007-2012
Table 68 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2007-2012
EYE CARE IN NEW ZEALAND
SECTOR DATA
Table 69 Sales of Eye Care by Subsector: Value 2002-2007
Table 70 Sales of Eye Care by Subsector: % Value Growth 2002-2007
Table 71 Standard Eye Care by Type 2007
Table 72 Eye Care Company Shares by Value 2003-2007
Table 73 Eye Care Brand Shares by Value 2004-2007
Table 74 Forecast Sales of Eye Care by Subsector: Value 2007-2012
Table 75 Forecast Sales of Eye Care by Subsector: % Value Growth 2007-2012
EAR CARE IN NEW ZEALAND
SECTOR DATA
Table 76 Sales of Ear Care: Value 2002-2007
Table 77 Sales of Ear Care: % Value Growth 2002-2007
Table 78 Ear Care Company Shares by Value 2003-2007
Table 79 Ear Care Brand Shares by Value 2004-2007
Table 80 Forecast Sales of Ear Care: Value 2007-2012
Table 81 Forecast Sales of Ear Care: % Value Growth 2007-2012
ADULT MOUTH CARE IN NEW ZEALAND
SECTOR DATA
Table 82 Sales of Adult Mouth Care: Value 2002-2007
Table 83 Sales of Adult Mouth Care: % Value Growth 2002-2007
Table 84 Adult Mouth Care Company Shares by Value 2003-2007
Table 85 Adult Mouth Care Brand Shares by Value 2004-2007
Table 86 Forecast Sales of Adult Mouth Care: Value 2007-2012
Table 87 Forecast Sales of Adult Mouth Care: % Value Growth 2007-2012
CALMING AND SLEEPING PRODUCTS IN NEW ZEALAND
SECTOR DATA
Table 88 Sales of Calming and Sleeping Products: Value 2002-2007
Table 89 Sales of Calming and Sleeping Products: % Value Growth 2002-2007
Table 90 Calming and Sleeping Products Company Shares by Value 2003-2007
Table 91 Calming and Sleeping Products Brand Shares by Value 2004-2007
Table 92 Forecast Sales of Calming and Sleeping Products: Value 2007-2012
Table 93 Forecast Sales of Calming and Sleeping Products: % Value Growth 2007-2012
WOUND TREATMENTS IN NEW ZEALAND
SECTOR DATA
Table 94 Sales of Wound Treatments by Subsector: Value 2002-2007
Table 95 Sales of Wound Treatments by Subsector: % Value Growth 2002-2007
Table 96 Wound Treatments Company Shares by Value 2003-2007
Table 97 Wound Treatments Brand Shares by Value 2004-2007
Table 98 Forecast Sales of Wound Treatments by Subsector: Value 2007-2012
Table 99 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2007-2012
OTC OBESITY IN NEW ZEALAND
SECTOR DATA
Table 100 Sales of OTC Obesity: Value 2004-2007
Table 101 Sales of OTC Obesity: % Value Growth 2004-2007
Table 102 Forecast Sales of OTC Obesity: Value 2007-2012
Table 103 Forecast Sales of OTC Obesity: % Value Growth 2007-2012
EMERGENCY CONTRACEPTION IN NEW ZEALAND
SECTOR DATA
Table 104 Sales of Emergency Contraception: Value 2002-2007
Table 105 Sales of Emergency Contraception: % Value Growth 2002-2007
Table 106 Forecast Sales of Emergency Contraception: Value 2007-2012
Table 107 Forecast Sales of Emergency Contraception: % Value Growth 2007-2012